Skip to main content
PLOS Biology logoLink to PLOS Biology
. 2021 Apr 27;19(4):e3001231. doi: 10.1371/journal.pbio.3001231

The structure of MgtE in the absence of magnesium provides new insights into channel gating

Fei Jin 1, Minxuan Sun 1, Takashi Fujii 2,3, Yurika Yamada 2, Jin Wang 4, Andrés D Maturana 5, Miki Wada 6, Shichen Su 7, Jinbiao Ma 7, Hironori Takeda 8, Tsukasa Kusakizako 9, Atsuhiro Tomita 9, Yoshiko Nakada-Nakura 10, Kehong Liu 10, Tomoko Uemura 10, Yayoi Nomura 10, Norimichi Nomura 10, Koichi Ito 6, Osamu Nureki 9, Keiichi Namba 2,3, So Iwata 10,11, Ye Yu 4, Motoyuki Hattori 1,*
Editor: Raimund Dutzler12
PMCID: PMC8104411  PMID: 33905418

Abstract

MgtE is a Mg2+ channel conserved in organisms ranging from prokaryotes to eukaryotes, including humans, and plays an important role in Mg2+ homeostasis. The previously determined MgtE structures in the Mg2+-bound, closed-state, and structure-based functional analyses of MgtE revealed that the binding of Mg2+ ions to the MgtE cytoplasmic domain induces channel inactivation to maintain Mg2+ homeostasis. There are no structures of the transmembrane (TM) domain for MgtE in Mg2+-free conditions, and the pore-opening mechanism has thus remained unclear.

Here, we determined the cryo-electron microscopy (cryo-EM) structure of the MgtE-Fab complex in the absence of Mg2+ ions. The Mg2+-free MgtE TM domain structure and its comparison with the Mg2+-bound, closed-state structure, together with functional analyses, showed the Mg2+-dependent pore opening of MgtE on the cytoplasmic side and revealed the kink motions of the TM2 and TM5 helices at the glycine residues, which are important for channel activity. Overall, our work provides structure-based mechanistic insights into the channel gating of MgtE.


MgtE is a magnesium-selective ion channel whose gating is regulated by cytoplasmic magnesium concentration; this cryo-EM study reveals how MgtE undergoes magnesium-dependent structural changes to open the pore on the cytoplasmic side.

Introduction

Mg2+ ions are biologically essential elements involved in various physiological processes, including the catalytic action of numerous enzymes, the utilization and synthesis of ATP, and the stabilization of RNA and DNA [13]. Accordingly, Mg2+ homeostasis is a requisite for all living organisms, and Mg2+ channels and transporters are pivotal in Mg2+ homeostasis [47].

MgtE belongs to a MgtE/SLC41 family of Mg2+ channels and transporters that are ubiquitously distributed in eukaryotes, eubacteria, and archaea [812]. Bacterial MgtE is a Mg2+-selective ion channel involved in Mg2+ homeostasis [13,14] and is also implicated in bacterial survival after antibiotic exposure [15]. Whereas MgtE was named as a transporter when the gene was cloned, the following patch clamp analyses of MgtE from Thermus thermophilus by single-channel recording showed a high conductance for Mg2+, and the channel activity was neither pH nor Na+ dependent [14,16,17]. Furthermore, MgtE does not hydrolyze ATP [17]. These results are most consistent with the bacterial MgtE acting as an ion channel.

The human orthologs of MgtE, the SLC41 proteins (SLC41A1, SLC41A2, and SLC41A3), also transport Mg2+ ions [10,1820], and mutations in these proteins are associated with type 2 diabetes [21], Parkinson disease [22], and nephronophthisis [23]. In contrast to bacterial MgtE as a channel, some of the SLC41 proteins (SLC41A1) are reported to be secondary active transporters driven by Na+ ions [24]. This situation is similar to the case with the CLC family proteins, which consist of 2 distinct subgroups of Cl channels and Cl/H+ transporters [2529].

The previously determined crystal structures of MgtE from T. thermophilus revealed the homodimeric architecture of MgtE, consisting of transmembrane (TM) and cytoplasmic domains connected via a long soluble helix, named the “plug” [30]. A high-resolution structure of the MgtE TM domain revealed the ion selectivity filter of MgtE with the fully hydrated Mg2+ ion in the ion-conducting pore [16]. The cytoplasmic domain of MgtE is composed of 2 subdomains, namely, the N and cystathionine-beta-synthase (CBS) domains. In the full-length MgtE structure in the presence of Mg2+ ions, the binding of multiple Mg2+ ions at the subunit interfaces of the cytoplasmic domain appears to stabilize the closed conformation of MgtE by fixing the orientation of the plug helices to close the ion-conducting pore (Fig 1A). The crystal structure of the Mg2+-free cytoplasmic domain exhibits a more relaxed conformation, where the N domain is dissociated from the CBS domain and where each subunit of the CBS domain and plug helix dimer are also separated from each other, which may unlock the closed conformation of the channel (Fig 1B and 1C). Consistent with this, electrophysiological recording of MgtE showed that a high concentration of cellular Mg2+ inhibits the channel gating of MgtE, whereas MgtE is in equilibrium between the open and closed states of the channel at a low concentration of cellular Mg2+ [14]. However, due to the lack of a MgtE TM domain structure in Mg2+-free conditions, the Mg2+-dependent structural changes in MgtE, particularly those in the TM domain, remain unknown, and thus, the channel-opening mechanisms remain unclear.

Fig 1. Functional characterization of Fab705.

Fig 1

(A) MgtE dimer in the presence of Mg2+ (PDB ID:2ZY9), viewed parallel to the membrane. The N and CBS domains, plug helix and TM domain in chain A, are colored blue, green, yellow and salmon, respectively. The other subunit (chain B) is colored cyan. Mg2+ ions are depicted as purple spheres. (B, C) Structural comparison of the Mg2+-bound (PDB ID:2YVY) and Mg2+-free (PDB ID:2YVZ) MgtE cytoplasmic domains superimposed on the CBS domains and viewed from the cytoplasmic side (B) and parallel to the membrane (C). The black arrows and red bars denote the rotation of the N domain (B) and plug helices (C). The N and CBS domains, plug helix of the Mg2+-free state, are colored blue, green, and yellow, respectively, whereas the Mg2+-bound state structure is colored gray. (D, E) Representative ITC profiles of MgtE with Fab705 in the presence of 0 mM MgCl2 (D) and 20 mM MgCl2 (E). (F, G) Single-channel recording of MgtE in the inside-out configuration from E. coli giant spheroplasts at −60 mV. Numbers within and outside trapezoids indicate MgCl2 concentrations in pipettes and bath solutions, respectively. Representative current traces from triple-knockout E. coli spheroplasts expressing MgtE in the presence (lower) or absence (upper) of 2 μM Fab705. (H) The open probabilities for MgtE with (+) and without (−) 2 μM Fab705 (n = 6 for each condition, p = 0.804). Error bars represent the standard error of the mean. The individual numerical values that underlie the summary data displayed in this figure can be found in S1 Data. CBS, cystathionine-beta-synthase; ITC, isothermal titration calorimetry; TM, transmembrane.

Here, we determined the cryo-electron microscopy (cryo-EM) structure of the MgtE-Fab complex in the absence of Mg2+ ions. The Mg2+-free MgtE structure revealed the cytoplasmic pore-opening motions of the MgtE TM domain. Structure-based functional analyses further clarified these structural changes on the cytoplasmic side, providing mechanistic insights into the channel gating of MgtE.

Results

Generation of the Fab antibody for MgtE

Many years of efforts to crystallize MgtE in Mg2+-free conditions yielded only poorly diffracting crystals. Thus, we decided to employ single-particle cryo-EM to determine the structure of MgtE in Mg2+-free conditions. However, it was still a challenge to obtain a high-resolution structure of full-length MgtE by cryo-EM due to its low molecular mass. Therefore, we attempted to generate Fab antibodies for MgtE to enable determination of the cryo-EM structure of the MgtE-Fab complex by increasing its total molecular mass.

After mouse immunization and generation of multiple monoclonal antibodies for MgtE, fluorescence detection size exclusion chromatography (FSEC) analysis showed that one of the Fab fragments, Fab705, bound to full-length MgtE with 0 mM Mg2+, as indicated by the apparent peak shift (S1A Fig), but the binding did not occur at a high concentration of Mg2+ (20 mM) (S1B Fig). Consistent with this, isothermal titration calorimetry (ITC) analysis showed that Fab705 bound to full-length MgtE with 0 mM MgCl2, with a Kd of 216.1 ± 52.7 nM, whereas no interaction was detected between Fab705 and MgtE at a high concentration of Mg2+ (20 mM) (Fig 1D and 1E, S1 Table). We then performed patch clamp analysis of full-length MgtE using Escherichia coli giant spheroplasts at 0 mM MgCl2 in the presence and absence of Fab705 and observed little change in the open probabilities upon addition of Fab705 into the bath solution (Fig 1F and 1H). Furthermore, in the patch clamp recording, when we tested a high concentration of MgCl2 (20 mM MgCl2) in the bath solution after the addition of Fab705, we did not observe channel opening, as similarly observed with a high concentration of MgCl2 in the absence of Fab705 (Fig 1G). These results demonstrate that Fab705 binds to Mg2+-free MgtE but not to MgtE with high Mg2+ concentrations and neither positively nor negatively modulate channel opening at 0 mM Mg2+. These functional properties of Fab705 are desirable for the determination of the MgtE structure under Mg2+-free conditions because it does not affect channel gating under Mg2+-free conditions, particularly in an inhibitory manner. Thus, the utilization of Fab705 enables the gating motions of MgtE to be captured by cryo-EM.

Cryo-EM of the MgtE-Fab complex in Mg2+-free conditions

To determine the structure of MgtE in the absence of Mg2+ or other divalent cations, the full-length MgtE-Fab705 complex was reconstituted in PMAL-C8 amphipol and subjected to cryo-EM single-particle analysis (Fig 2, S2 and S3 Figs). A 3D reconstruction of the cryo-EM images was performed to reach an overall resolution of 3.7 Å, with C2 symmetry imposed (Fig 2C), and the cryo-EM density of the TM domain was clear enough to build an atomic model (Fig 2D–2F, S4 Fig). An additional cryo-EM density map of the TM domain was calculated at an approximately 3.1 Å resolution by signal subtraction and additional 3D refinement (S5 Fig).

Fig 2. Cryo-EM of the MgtE-Fab complex.

Fig 2

(A) Representative cryo-EM image at −1.8 μm defocused with MgtE-Fab complex particles. (B) Selected 2D class averages used to produce the 3D reconstruction. (C) Gold standard FSC for estimating resolution. (D–F) Side (D), periplasmic (E), and intracellular (F) views of the final map colored according to local resolution, calculated using RELION. The individual numerical values that underlie the summary data displayed in this figure can be found in S1 Data. cryo-EM, cryo-electron microscopy; FSC, Fourier shell correlation; TM, transmembrane.

Notably, we did not detect the cryo-EM density of the cytoplasmic domain of MgtE. SDS-PAGE analysis showed the presence of the cytoplasmic domain of MgtE in the purified sample for cryo-EM (S2 Fig), and thus, the absence of the MgtE cytoplasmic domain in the cryo-EM density was probably because of the high structural flexibility of the Mg2+-free cytoplasmic domain [30,31]. The highly flexible nature of the Mg2+-free MgtE cytoplasmic domain in our cryo-EM structure is consistent with previous studies conducted on MgtE by high-speed atomic force microscopy (HS-AFM) [32] and molecular dynamics (MD) simulations [31]. In particular, the HS-AFM results directly visualized the continuous shaking motions of the MgtE cytoplasmic domains under Mg2+-free conditions. The flexibility of the MgtE cytoplasmic domain in Mg2+-free conditions is necessary for unlocking the closed conformation of the MgtE TM domain for channel opening [14].

Nevertheless, the details of the structural changes in the TM domain following the release of Mg2+ ions from the cytoplasmic domain were previously unclear, and for the first time, we have successfully visualized the conformation of the TM domain under Mg2+-free conditions.

MgtE forms a symmetric dimer, and each subunit is composed of 5 TM helices (Fig 3). The Fab705 molecules are bound to the cytoplasmic side of the MgtE TM domain, and this binding is mediated mainly by electrostatic interactions and hydrogen bonds, primarily involving the residues in the TM2 to TM3 linker and the TM4 to TM5 linker (Fig 3A, S6A Fig). Among these residues involved in Fab binding, Arg345 interacts with Glu217 in the CBS domain, and Asp418 binds to Mg2+ ions to bridge the TM domain and plug helices in the full-length MgtE structure in the Mg2+-bound form (PDB ID: 2ZY9) (S6B Fig).

Fig 3. Overall structure.

Fig 3

(A) Cartoon representation of the MgtE-Fab complex dimer under Mg2+-free conditions, viewed parallel to the membrane. The MgtE TM domain dimer is indicated in salmon (chain A) and cyan (chain B). The Fab fragments are colored in gray. (B, C) The MgtE dimer, viewed from the periplasm (B) and from the cytoplasm (C). TM, transmembrane.

The superposition of our cryo-EM structure and the MgtE cytoplasmic domain structure in Mg2+-free conditions (PDB ID: 2YVZ) onto the crystal structure of full-length MgtE in the presence of Mg2+ (PDB ID: 2ZY9) (S7 Fig) reveals the spatial collision between the Fabs and the Mg2+-bound cytoplasmic domain, mainly at the N domain (S7B Fig), whereas the N domain is dissociated from the CBS domain in the absence of Mg2+ (S7B Fig): This explains why we did not observe binding between MgtE and Fab705 at a high concentration of Mg2+.

Notably, in FSEC analysis, the addition of 20 mM Mg2+ into the sample of the MgtE-Fab complex sample, which was preformed before the addition of Mg2+, disrupted complex formation, where we did not see a Fab-dependent FSEC peak shift (S1C Fig), consistent with the patch clamp recording at a high concentration of MgCl2 (20 mM MgCl2) in the bath solution (Fig 1G). These results indicate that after Fab binding, a high concentration of Mg2+ ions can still close the MgtE channel by disrupting the MgtE-Fab complex.

We then compared our structure with the previously determined Mg2+-bound, closed-state MgtE structure (PDB ID: 2ZY9) and performed further functional analysis to gain structural insight into MgtE channel opening.

Ion-conducting pore

The MgtE structure possesses an ion-conducting pore at the center of the dimer in the Mg2+-bound, closed state (Fig 4). The MgtE structure in Mg2+-free conditions has a wider pore on the cytoplasmic side than that in the previously determined structure in the presence of Mg2+ ions (PDB ID: 2ZY9) (Fig 4C). Notably, at the cytoplasmic end of the pore, the side chains of Asn424 of both subunits face each other in the Mg2+-bound closed structure (PDB ID: 2ZY9) (Fig 4B), whereas in our new Mg2+-free structure, the side chains of Asn424 are turned away from each other (Fig 4A) to form a wider cytoplasmic pore, suggesting that this region might form the cytoplasmic gate. In addition, Asn332 is in close contact with Asn424, seemingly contributing to the formation of the cytoplasmic gate (Fig 4B).

Fig 4. Ion-conducting pore.

Fig 4

(A, B) The solvent-accessible surface of the MgtE pore under Mg2+-free conditions (A) and in the presence of Mg2+ (B) (PDB ID:2ZY9) with the pore-lining residues. Mg2+-free MgtE is colored salmon (chain A) and cyan (chain B). Mg2+-bound MgtE is colored gray. A close-up view of the cytoplasmic gate in the Mg2+-bound state is also shown with semitransparent surface representation (B). Hydrogen bonds are denoted by dashed lines. A cartoon representation of the MgtE TM domain dimer under Mg2+-free conditions is also shown (A). (C) Plots of the pore radius of MgtE structures in Mg2+-free and Mg2+-bound states. (D) Ni2+ sensitivity assay of the WT E. coli strain. Serially diluted cultures (10−1, 10−2, 10−3, 10−4, and 10−5) of magnesium-prototrophic WT E. coli (W3110 DE3) transformants harboring expression plasmids (empty vector, WT MgtE, N332A MgtE, N424A MgtE, and ΔN MgtE) were spotted onto the assay LB plates supplemented with 10 μM IPTG (moderate T7 promoter induction): (left) no additional NiCl2, (right) + 1.4 mM NiCl2. The individual numerical values that underlie the summary data displayed in this figure can be found in S1 Data. IPTG, isopropyl-β-D-thiogalactoside; TM, transmembrane; WT, wild-type.

To test this hypothesis, we generated MgtE mutants possessing an alanine substitution at Asn332 or Asn424, which may disrupt the cytoplasmic gate (N332A and N424A). We conducted a Ni2+ sensitivity assay in E. coli using the N332A- and N424A-MgtE mutants. The coordination chemistry required for Ni2+ is highly similar to that of Mg2+, and MgtE and other Mg2+ channels typically transport Ni2+ [7]. We employed Ni2+, not Mg2+, for the sensitivity assay in E. coli because Ni2+ is much more toxic to E. coli cells than Mg2+: Therefore, Ni2+ is more suitable to evaluate the change in the sensitivities in E. coli. Increased sensitivity to Ni2+ indicates up-regulation of Ni2+ uptake, and the change in the sensitivities to Ni2+ was already previously employed to characterize MgtE and its mutants in the past [17]. E. coli cells expressing the N332A and N424A mutants of MgtE exhibited increased Ni2+ sensitivity (Fig 4D) compared to cells expressing wild-type MgtE, suggesting that the disruption of the cytoplasmic gate led to increased Ni2+ uptake.

In contrast to the opening of the cytoplasmic side of the pore, the pore remains closed around the Ala317 residues on the periplasmic side, where the pore radius is approximately 1 Å (Fig 4C) in both MgtE structures in the presence and absence of Mg2+ ions, indicating that the current structure would remain in a nonconductive conformation on the periplasmic side.

Cytoplasmic pore-opening motions

Consistent with the wider opening of the ion-conducting pore on the cytoplasmic side, the TM helices, including the pore-forming TM2 and TM5 helices, are located in exterior positions with respect to the center of the ion-conducting pore under Mg2+-free conditions (Fig 5A and 5B, S1 Video). Furthermore, the TM3 and TM4 helices have also moved away from the center, as they interact with both the TM2 and TM5 helices (Fig 5B). For instance, compared to the structure of the Mg2+-bound state, Thr344 at TM2, in the Mg2+-free state, Asp348 at TM3, Leu415 at TM4, and Ala420 at TM5 are rotated by approximately 8°, 5°, 8°, and approximately 14°, respectively, clockwise from the central axis along the pore and have moved away from the central axis by approximately 3 Å, approximately 3 Å, 3 Å, and approximately 1 Å, respectively.

Fig 5. Cytoplasmic pore-opening motions.

Fig 5

(A, B) Mg2+-free MgtE is superposed onto Mg2+-bound MgtE in the closed state (PDB ID:2ZY9) using the Cα positions of the TM domain dimer, viewed parallel to the membrane (A) and from the cytoplasm (B). Mg2+-free MgtE is colored salmon (chain A) and cyan (chain B). Mg2+-bound MgtE is colored gray. The black arrows indicate the structural changes between the Mg2+-bound and Mg2+-free structures. (C) A close-up view of the MgtE dimer interface on the cytoplasmic side. Dotted black lines indicate the Cβ distances between Thr336 and Leu421. (D) Representative SDS-PAGE results from chemical cross-linking experiments with the MgtE double cysteine mutant T336C/L421C. (E) Densitometric quantification and sigmoidal curve fitting of SDS-PAGE band intensities for the MgtE dimer (blue) and monomer (red). Experiments were repeated 6 times. Error bars represent the standard error of the mean. The individual numerical values that underlie the summary data displayed in this figure can be found in S1 Data. TM, transmembrane.

To verify the Mg2+-dependent structural changes in the TM helices on the cytoplasmic side, we generated MgtE mutants possessing cysteine substitutions at Leu421 and Thr336, where the Cα distances between Leu421 (A) and Thr336 (B) in the presence and absence of Mg2+ ions were 5.2 and 14.0 Å, respectively (Fig 5C). Using Cu2+ phenanthroline as a catalyst, cross-linking experiments were performed with these mutants (Fig 5D and 5E). Wild-type MgtE does not contain any endogenous cysteine residues, and the addition of MgCl2 to MgtE would shift the equilibrium from the Mg2+-free form to the Mg2+-bound form, according to the previously reported limited proteolysis assay of MgtE [14]. The double cysteine mutant T336C/L421C exhibited a strong band corresponding to the MgtE dimer in the presence of Mg2+ at a concentration gradient (0.01 to 30 mM) and Cu2+ phenanthroline (Fig 5D and 5E), consistent with the Mg2+-dependent structural changes observed in our cryo-EM structure.

To further support the current conformation of the MgtE TM domain structure, we performed MD simulations starting from the Mg2+-free MgtE TM domain structure embedded in the lipid bilayer. The results of the 3-μs simulation in the absence of Mg2+ showed that the structures of the MgtE TM domain are mostly stable (S8A Fig). The cytoplasmic pore remained open, with Cα distances between Leu421 (A) and Thr336 (B) of 10 to 15 Å (S8B and S8C Fig), whereas the periplasmic gate region site remained closed, with stable Cα distances between Ala317 (A) and Ala317 (B) of approximately 6 Å during the MD simulations (S8D Fig). The results further support the cytoplasmic pore opening of MgtE under Mg2+-free conditions, as we observed in the cryo-EM structure. At the same time, we also do not exclude the possibility that we might see some structural changes if we run the MD simulation for a much longer duration.

Kink motions of the TM helices for channel gating

Detailed observation and comparison of the MgtE structures further revealed the kink motions of TM2 at Gly325 and Gly328 by approximately 10° and of TM5 at Gly435 by approximately 10° (Fig 6A and 6B). Since the TM2 and TM5 helices form the ion-conducting pore, these kink motions seemingly enable the TM2 and TM5 helices to expand the pore on the cytoplasmic side.

Fig 6. Kink motions of the TM helices.

Fig 6

(A, B) Structural changes in the TM2 (A) and TM5 (B) helices. The TM helices of Mg2+-free MgtE (red) are superimposed on those of Mg2+-bound MgtE (gray) (PDB ID:2ZY9) using the Cα positions of residues 313–325 for TM2 and 435–447 for TM5. Gly325, Gly328, and Gly435 in Mg2+-free MgtE are depicted as stick representations. (C) Mg2+-auxotrophic growth complementation assay of MgtE and its mutants on −Mg2+ plates. Serially diluted cultures (10−2, 10−3, 10−4, and 10−5) of Mg2+-auxotrophic E. coli transformants harboring expression plasmids (vector, WT MgtE, G325A MgtE, G328A MgtE, and G435A MgtE) were spotted onto the assay LB plates. TM, transmembrane; WT, wild-type.

To examine the functional importance of these glycine residues, we generated a series of alanine-substituted mutants of MgtE (G325A, G328A, and G435A) and performed a growth complementation assay using a Mg2+-auxotrophic E. coli strain lacking the major genes (ΔmgtA ΔcorA ΔyhiD) encoding Mg2+ transporters that survived only when the medium was supplemented with a sufficiently high concentration of Mg2+ [14]. The exogenously expressed MgtE could reconstitute the Mg2+ transport activity of this strain, and the strain transformed with the wild-type MgtE gene could survive in Mg2+-free LB medium [14]. While the expression of wild-type MgtE rescued Mg2+-auxotrophic growth, the expression of the mutations at these glycine residues almost lost Mg2+-auxotrophic growth complementation activity (Fig 6C). In particular, mutation of the strictly conserved Gly328 completely eliminated the growth complementation activity (Fig 6C). These results indicated that these glycine residues at the kinks of the TM2 and TM5 helices are important for the channel activity of MgtE.

Discussion

In this work, we determined the cryo-EM structure of MgtE in Mg2+-free conditions. The utilization of antibodies has been successfully applied to the single-particle analysis of membrane proteins [3337]. Notably, in our MgtE-Fab complex structure, the ordered region of MgtE (MgtE TM domain dimer) has a molecular mass of only 39 kDa, further demonstrating antibody-based techniques to be powerful tools for the determination of membrane protein structures by cryo-EM. Notably, Fab705 employed for cryo-EM does not have inhibitory effects on the channel opening under Mg2+-free conditions (Fig 1F), which would be desirable for determining the MgtE structure under Mg2+-free conditions (S9 Fig) because Fabs with inhibitory effects on channel gating may hinder structural changes in the TM domain, which would not be suitable to gain structural insights into the channel gating. Based on this structure, we further conducted structure-based functional analysis, and our new findings together with our previous research on MgtE provided structural insights into the gating mechanism of MgtE, as discussed below.

First, under high Mg2+ concentrations, the binding of intracellular Mg2+ to the cytoplasmic domain of MgtE, including the plug helices, stabilizes the tightly packed, closed conformation of the protein, leading to pore closure in the TM domain through extensive interactions between the plug helices and the TM domain, mainly via helices TM2 and TM5 on the cytoplasmic side [30] (Figs 1A and 7A).

Fig 7. Proposed mechanism.

Fig 7

A cartoon representation of the proposed gating motions in the presence of Mg2+ (A) and under Mg2+-free conditions (B). MgtE TM domain, plug helix, CBS domain, and N domain are depicted in red, yellow, green, and blue, respectively. The purple circles represent magnesium ions. The yellow circles containing the letter G emphasize the kink motions at the glycine residues (Gly325, Gly328, and Gly435). The black arrows indicate the structural changes between the Mg2+-bound state and the Mg2+-free structures. Curved black lines indicate the flexibility of the cytoplasmic domain under Mg2+-free conditions. CBS, cystathionine-beta-synthase; TM, transmembrane.

In contrast, under Mg2+-free conditions, the MgtE cytoplasmic domain, including the plug helices, was totally disordered and could not be built into the cryo-EM map, indicating the highly flexible nature of the MgtE cytoplasmic domain under Mg2+-free conditions (Fig 7B). In such disordered conditions, the plug helices of MgtE cannot tightly interact with the TM domain to lock the channel in the closed state anymore, unlike the structure in the Mg2+-bound state (Figs 1A and 7A). In other words, under Mg2+-free conditions, the high flexibility of the cytoplasmic domain leads to the loss of the interactions between the plug helices and the TM domains, unlocking the TM domain conformation from the closed state. Highly flexible domain motions in the MgtE cytoplasmic domain were also observed by HS-AFM [32], in the crystal structure of the Mg2+-free cytoplasmic domain structure [30], and via MD simulations of MgtE [31]. In particular, in a previous report on HS-AFM [32], Haruyama and colleagues observed a jagged topography of MgtE in the absence of Mg2+ under HS-AFM from the end-up orientation (cytoplasmic view), indicating that the cytoplasmic domains are constantly fluctuating. Furthermore, they observed that in the side-on orientation (side view), the cytoplasmic regions of MgtE were highly flexible and ambiguous in the absence of Mg2+, and successive images demonstrated the association and disassembly of the N and CBS domains in solution. Such disassembly of the N and CBS domains is consistent with the previous structure of the MgtE cytoplasmic domain under Mg2+-free conditions (Figs 1B and 7B). Intriguingly, similar types of regulatory mechanisms, in which the cytoplasmic domain undergoes a transition from a rigid conformation to a highly flexible or disordered state upon the release of ligands from the cytoplasmic domain, have been observed in other channels/transporters such as the CLC Cl channel and the OpuA ABC transporter, which also possesses a CBS domain [38,39].

Following the unlocking of the TM domain due to the high flexibility of the Mg2+-free cytoplasmic domain, we observed the structural differences of the TM domains between our cryo-EM structure and the previously determined Mg2+-bound, inactivated structure (Fig 5). In our cryo-EM structure, the ion-conducting pore is wide open on the cytoplasmic side but still closed on the periplasmic side (Fig 4), indicating that the pore is still nonconductive. According to previous patch clamp recording results, MgtE is in equilibrium between the open and closed states under low-Mg2+ conditions rather than in a constitutively open state [14]. Therefore, our cryo-EM structure of MgtE may represent a preopening state of MgtE under low-Mg2+ conditions, where the pore is partially opened on the cytoplasmic side due to loss of the tight interactions with the plug helices (Fig 7B). Intriguingly, after the 3-μs MD simulation of the Mg2+-free, MgtE TM domain structure was performed by adding Mg2+ ion to the Mg2+ binding site in the pore; the entrance region of the periplasmic side between the TM1 and TM2 helices became partially opened, with Cα distances between Glu311 (A) and Glu311 (B) of approximately 12 Å (S8E–S8G Fig), whereas the periplasmic gate remained nonconductive, with Cα distances between Ala317 (A) and Ala317 (B) of approximately 6 Å (S8D Fig). To fully understand the gating cycle of the MgtE channel, a structure in a fully opening state is still required. Furthermore, whereas the previous results are most consistent with the bacterial MgtE acting as an ion channel [14,16,17], since some of the SLC41 proteins, the eukaryotic counterparts of the bacterial MgtE, are Na+-driven Mg2+ transporters [24], the understanding of their transport mechanism would require structural analysis of eukaryotic SLC41 proteins.

In our structure, the structural changes in the TM domain occur mainly at the TM2 and TM5 helices (Figs 5 and 7B), and the glycine residues in the TM2 and TM5 helices enable the kink motions of the TM2 and TM5 helices for cytoplasmic pore opening (Figs 6 and 7B). We verified these structural changes by biochemical cross-linking experiments and genetic assays (Figs 4D, 5D, 5E and 6C). Notably, none of these functional experiments to verify the structural changes were performed in the presence of Fab705, suggesting that these structural changes in our MgtE-Fab complex structure are unlikely to be nonphysiological artifacts due to the use of Fab for structure determination.

Taken together, our structural and functional analyses provide mechanistic insight into the channel-opening mechanisms of MgtE, particularly cytoplasmic pore opening.

Materials and methods

Preparation of the MgtE-Fab complex

The full-length T. thermophilus MgtE gene was subcloned into a pET28a-derived vector containing an N-terminal hexahistidine tag and a human rhinovirus 3C (HRV3C) protease cleavage site, as described previously [30]. The protein was overexpressed in E. coli C41 (DE3) cells in LB medium containing 30 μg/ml kanamycin at 37°C by induction at an OD600 of approximately 0.5 with 0.5 mM isopropyl-β-D-thiogalactoside (IPTG) for 16 hours at 18°C. The cells were subsequently harvested by centrifugation (6,000 × g, 15 minutes) and resuspended in buffer H [50 mM HEPES (pH 7.0), 150 mM NaCl, 0.5 mM phenylmethanesulfonyl fluoride (PMSF)]. All purification steps were performed at 4°C. The cells were then disrupted with a microfluidizer, and the supernatants were collected after centrifugation (20,000 × g, 30 minutes) and ultracentrifugation (200,000 × g, 1 hour). Next, the membrane fraction was solubilized with buffer S [50 mM HEPES (pH 7.0), 150 mM NaCl, 2% (w/v) n-dodecyl-beta-d-maltopyranoside (DDM) (Anatrace, United States of America) and 0.5 mM PMSF] for 2 hours. The solubilized fraction was loaded onto a Ni-NTA column pre-equilibrated with buffer A [50 mM HEPES (pH 7.0), 150 mM NaCl, and 0.05% (w/v) DDM] containing 20 mM imidazole and mixed for 1 hour. The column was then washed with buffer A containing 50 mM imidazole, and the protein was eluted with buffer A containing 300 mM imidazole. The N-terminal hexahistidine tag was cleaved by HRV3C protease against dialysis buffer (buffer A containing 20 mM imidazole) overnight, and the cleaved protein was reloaded onto a Ni-NTA column pre-equilibrated with dialysis buffer.

The flow-through fraction from the column was collected and concentrated using an Amicon Ultra 50K filter (Merck Millipore, USA) and then loaded onto a Superdex 200 10/300 size exclusion chromatography (SEC) column (GE Healthcare, USA) in buffer B [20 mM HEPES (pH 7.0), and 150 mM NaCl] containing 0.05% (w/v) DDM. The main peak fractions from the column were collected and mixed with PMAL-C8 amphipol (Anatrace) at a ratio of 1:5 (w:w) overnight. The sample was mixed with Bio-Beads SM-2 (Bio-Rad, USA) and rotated gently for 4 hours. The Bio-Beads were subsequently removed by a disposable Poly-Prep column, and the eluents were concentrated using an Amicon Ultra 50K filter and loaded onto a Superdex 200 10/300 SEC column in buffer B. The SEC fractions corresponding to the amphipol-reconstituted MgtE were collected, mixed with the Fab antibody fragment Fab705 at a ratio of 1:2 (w:w) for 1 hour, and applied to a Superdex 200 10/300 SEC column in buffer B. The SEC fractions corresponding to the MgtE-Fab complex were collected and concentrated to approximately 1 mg/ml with an Amicon Ultra 50K filter for single-particle analysis using cryo-EM.

EM data acquisition and analysis

A total of 4.0 μl of the MgtE-Fab complex in PMAL-C8 was applied to a glow-discharged holey carbon-film grid (Zhongkexinghua BioTech, GiG-A31213, 300M-Au-R1.2/1.3, China) blotted with a Vitrobot (FEI, USA) system using a 1.0-second blotting time with 100% humidity at 9°C and plunge-frozen in liquid ethane. Cryo-EM images were collected on a Titan Krios (FEI) electron microscope operated at an acceleration voltage of 300 kV. The specimen stage temperature was maintained at 80 K. Images were recorded with a K2 Summit direct electron detector camera (Gatan, USA) set to super-resolution mode with a pixel size of 0.41 Å (a physical pixel size of 0.82 Å) and a defocus ranging from −1.5 μm to −2.3 μm. The dose rate was 8 e- s–1, and each movie was 6-second long, dose-fractioned into 40 frames with an exposure of 1.75 e- Å–2 for each frame. The cryo-EM data are summarized in S2 Table.

Image processing

A total of 5,610 movies of the MgtE-Fab complex were motion-corrected and binned with MotionCor2 [40] with 5 × 5 patches, producing summed and dose-weighted micrographs with a pixel size of 0.82 Å. Contrast transfer function (CTF) parameters were estimated by CTFFIND 4.1 [41]. Particle picking and further image processing were performed using RELION 3.0 [42]. A total of 1,860,461 particles were autopicked and extracted with a box size of 256 × 256 pixels. After several rounds of 2D classification, the re-extracted particles were classified into 12 classes for 3D classification without any symmetry imposed. Refinement and postprocessing using RELION produced a final map at a 3.7 Å resolution from 168,911 particles with C2 symmetry imposed. The final 3D reconstruction was calculated from 2 × 2 binned images (0.82 Å). The final resolution was estimated using the Fourier shell correlation (FSC) = 0.143 criterion on the corrected FSC curves, in which the influence of the mask was removed. The local resolution was estimated using RELION. The workflow for image processing and for the 3D reconstruction and angular distribution plot are shown in S3 Fig.

Model building

The initial model of Mg2+-free MgtE-Fab was manually built starting from the MgtE TM domain structure and the homology model of Fab705 generated by SWISS-MODEL [43]. Manual model building was performed using Coot [44]. Real-space refinement was performed using PHENIX software [45]. The final atomic model of MgtE includes residues 271 to 448 for chains A and B. All figures showing structures were generated using PyMol (https://pymol.org/). The sequence alignment figure was generated using Clustal Omega [46] and ESPript 3.0 [47]. The MgtE pore shown in Fig 4 was calculated by HOLE [48].

Preparation of antibody fragments

Mouse monoclonal antibodies against MgtE were raised by an established method [49]. Briefly, a proteoliposome antigen was prepared by reconstituting purified, functional MgtE at high density in phospholipid vesicles consisting of a 10:1 mixture of egg phosphatidylcholine (Avanti Polar Lipids, USA) and the adjuvant lipid A (Sigma-Aldrich, USA) to facilitate the immune response. BALB/c mice immunization was performed with the proteoliposome antigen using 3 injections at 2-week intervals. Antibody-producing hybridoma cell lines were generated using a conventional fusion protocol [50]. Hybridoma clones producing antibodies recognizing conformational epitopes in MgtE were selected by an enzyme-linked immunosorbent assay on immobilized phospholipid vesicles containing purified MgtE (liposome ELISA), allowing positive selection of the antibodies that recognized the native conformation of MgtE. Additional screening for reduced antibody binding to SDS-denatured MgtE was used for negative selection against linear epitope-recognizing antibodies. Stable complex formation between MgtE and each antibody clone was checked using FSEC. From these screens, we isolated 4 MgtE-specific monoclonal antibodies: YN0705, YN0710, YN0721, and YN0736. Whole IgG molecules, collected from the large-scale culture supernatant of monoclonal hybridomas and purified using protein G affinity chromatography, were digested with papain, and Fab fragments were isolated using a HiLoad 16/600 Superdex 200 gel filtration column followed by protein A affinity chromatography. The cDNAs encoding the light and heavy chains of Fab YN0705 were cloned from hybridoma cells using rapid amplification of 5′ complementary DNA ends (5′-RACE) and sequenced.

Isothermal titration calorimetry

The binding affinities of the Fab antibody fragment Fab705 for full-length MgtE were measured using MicroCal iTC200 (GE Healthcare). The full-length MgtE proteins were purified by a similar procedure to that described above but with SEC buffer [buffer B containing 0.05% (w/v) DDM] containing either 0 or 20 mM MgCl2. Fab was also used for gel filtration with the same SEC buffer containing either 0 or 20 mM MgCl2. The peak fractions of MgtE were collected and diluted to approximately 2.5 μM (monomer) with SEC buffer, while Fab was diluted to 25 μM. Fab was injected into the cell containing the full-length MgtE 20 times (0.5 μl for injection 1, 2 μl for injections 2 to 20) at 25°C, with 120-second intervals between injections. The background data were measured by injecting the SEC buffer into a cell containing the full-length MgtE. The results were analyzed by Origin8 software (MicroCal). The experiments were repeated 3 times for each measurement, and similar results were achieved. All ITC profiles are shown in S10 Fig. The protein concentration was estimated using the absorbance at 280 nm.

Chemical cross-linking

The wild-type and mutant MgtE proteins were purified as described above, except that dithiothreitol (DTT) was added at a final concentration of 20 mM to the MgtE mutant proteins before removal by SEC, and then diluted to 0.5 mg/ml with buffer B containing 0.05% (w/v) DDM. MgtE proteins (4.0 μl) were mixed with 0.5 μl of MgCl2 at appropriate concentrations and incubated for 30 minutes at 4°C. Then, 0.5 μl of 10 mM Cu2+ bis-1,10-phenanthroline was added at a 1:3 molar ratio, and the samples were incubated for another 30 minutes at 4°C. The reaction mixtures were loaded with nonreduced loading buffer and analyzed immediately by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). The relative intensity of the bands was analyzed by ImageJ software and fitted to a sigmoidal equation. The experiments were repeated 6 times. All SDS-PAGE results are shown in S11 Fig.

Molecular dynamics simulations

As described previously [51,52], DESMOND [53] was used to perform MD analysis with a constant number of particles, constant pressure (1 bar) and temperature (300 K) (NPT), and periodic boundary conditions (PBCs) by using the Nose–Hoover chain thermostat and Martyna–Tobias–Klein barostat methods. The MgtE TM domain dimer was embedded in a phosphoryl-oleoyl phosphatidylcholine (POPC) bilayer. The structure of MgtE/POPC was solvated in an orthorhombic box of SPC water molecules. All-atom OPLS_2005 force fields for proteins, ions, lipids, and simple point charge (SPC) waters were used in all simulations [54,55]. Before performing simulations, a default relaxation protocol in DESMOND was employed: (1) NVT ensemble with Brownian dynamics for 100 ps at 10 K with small time step and solute heavy atom restrained; (2) NVT ensemble using Berendsen thermostat for 12 ps at 10 K with small time step and solute heavy atom restrained; (3) NPT ensemble using a Berendsen thermostat and barostat for 12 ps at 10 K and 1 atm with solute heavy atom restrained; (4) NPT ensemble using a Berendsen for 12 ps at 300 K and 1 atm with solute heavy atom restrained; and (5) NPT ensemble using a Berendsen for 24 ps at 300 K and 1 atm with no restraints. After the relaxation, MD simulation was performed for 200 ns. The integration time step used was 2 fs, and coordinate trajectories were saved every 200 ps. A DELL T7910 graphics workstation (with multiple NVIDA Tesla K40C GPUs) was used to run the MD simulations, and a 12-CPU CORE DELL T7500 graphics workstation was used to perform the preparation, analysis, and visualization. The Simulation Event Analysis module in DESMOND was used to analyze MD trajectories.

Electrophysiological recordings

Patch clamp recording of MgtE using E. coli giant spheroplasts was performed in the inside-out configuration, as described previously [14,56]. In brief, spheroplasts were placed in a bath solution containing 210 mM N-methyl-D-glucamine, 90 mM MgCl2, 300 mM D-glucose, and 5 mM HEPES (pH 7.2). After gigaseal formation with a borosilicate glass pipette (Harvard Apparatus, Kent, United Kingdom) with 6 to 8 mOhm resistance, the bath medium was changed to bath solution containing 300 mM N-methyl-D-glucamine, 300 mM D-glucose, and 5 mM HEPES (pH 7.2) by perfusion using a Rainer perfusion pump and a custom-made perfusion system. Bath medium containing 2 μM Fab705 was added by perfusion. The pipette solution contained 210 mM N-methyl-D-glucamine, 90 mM MgCl2, 300 mM sucrose, and 5 mM HEPES (pH 7.2). Currents were measured with an Axopatch 200B amplifier and recorded with a Digidata 1440B A/D converter under the control of pCLAMP software (Molecular Devices, USA). Currents were filtered at 2 kHz and recorded at 5 kHz. Additional reporting details regarding the electrophysiology experiments are shown in S12 Fig.

E. coli genetics

As described previously [14], the Mg2+-auxotrophic E. coli strain (BW25113 ΔmgtA ΔcorA ΔyhiD DE3) was transformed with MgtE or MgtE mutant plasmids and grown on LB medium plates containing 50 μg/ml kanamycin and 100 mM MgSO4. Each transformant was inoculated in liquid LB medium containing 50 μg/ml kanamycin and 100 mM MgSO4 and incubated at 37°C overnight with shaking. The liquid samples were diluted 1:100 with the same medium and grown until the OD600 reached 0.6. The sample cultures were then serially diluted 10-fold in LB medium containing 50 μg/ml kanamycin, spotted onto assay plates, and incubated at 37°C overnight, as indicated in Fig 6C.

In the Ni2+ sensitivity assay, the isogenic magnesium-prototrophic wild-type E. coli strain (W3110 DE3) was transformed with the plasmid, and transformants were obtained on LB (+50 μg/ml kanamycin) plates. The liquid samples were diluted 1:100 with the same medium and grown until the OD600 reached 0.6. The sample cultures were then serially diluted 10-fold and spotted onto assay plates, and the plates were incubated at 37°C overnight, as indicated in Fig 4D.

The expression of MgtE and its mutants was confirmed by western blotting (S13 and S14 Figs).

Western blot analysis

The Mg2+-auxotrophic E. coli strain (BW25113 ΔmgtA ΔcorA ΔyhiD DE3) was transformed with the plasmids, and transformants were obtained on LB (+50 μg/ml kanamycin) plates supplemented with 100 mM MgSO4. Each transformant was cultured in LB liquid medium supplemented with 50 μg/ml kanamycin and 100 mM MgSO4 overnight. The E. coli cell numbers were adjusted based on the OD600. Whole-cell extracts were prepared, resolved by SDS-PAGE (10% polyacrylamide), and transferred to Hybond-ECL (GE Healthcare). The transferred proteins were stained with an anti-His6 polyclonal antibody, anti-His-tag-HRP direct T (MBL, Japan). Antibody-bound proteins were visualized using western blot detection reagents (Immunostar LD, Wako Laboratory Chemicals, Japan). Images were captured with an LAS-3000 Mini imaging system (Fujifilm, Japan).

FSEC experiments

Purified full-length MgtE and Fab705 proteins were diluted to 1 mg/ml with buffer B containing 0.05% (w/v) DDM. The MgtE-Fab complex was formed by mixing MgtE and Fab at mass ratios of 1:0, 0:1, 1:0.5, 1:1, and 1:2 in the presence of 0 mM or 20 mM Mg2+. The samples were then loaded onto a Superdex 200 Increase 10/300 SEC column (GE Healthcare) connected to an RF-20Axs fluorescence detector (Shimadzu, Japan) (excitation: 280 nm, emission: 325 nm) with buffer B containing 0.05% (w/v) DDM and 0 mM or 20 mM Mg2+.

The complex disruption experiment was performed by adding Mg2+ at a final concentration of 20 mM to the preformed MgtE-Fab complex, which was prepared by mixing MgtE and Fab705 at a mass ratio of 1:2 in 0 mM Mg2+ and loading the sample on an FSEC column with buffer B containing 0.05% (w/v) DDM and 20 mM Mg2+.

Supporting information

S1 Fig. FSEC analysis of MgtE-Fab complex formation.

(A, B) FSEC analysis of MgtE-Fab complex formation. The MgtE-Fab complex was formed by adding Fab to MgtE in 0 mM MgCl2 (A) and in 20 mM MgCl2 (B) at the indicated mass ratios. The FSEC running buffer included 0 mM for (A) and 20 mM MgCl2 for (B). (C) The complex disruption experiment was performed by adding Mg2+ at a final concentration of 20 mM to the preformed MgtE-Fab complex, which was prepared by mixing MgtE and Fab705 at a mass ratio of 1:2 in 0 mM Mg2+. In addition to the FSEC profile for the complex disrupted sample (blue), the FSEC profiles of Fab-free MgtE in Mg2+-free conditions (orange) and 20 mM MgCl2 (gray) are also shown. The FSEC running buffer includes 20 mM MgCl2, except for the FSEC of MgtE in Mg2+-free conditions. In FSEC profiles, Mg2+-free MgtE (A, C) eluted earlier than Mg2+-bound MgtE (B, C), probably because the conformation of MgtE, in particular the conformation of the cytoplasmic domain of MgtE, is more compact in the presence of Mg2+ than in the absence of Mg2+ as shown in Fig 1B. FSEC, fluorescence detection size exclusion chromatography.

(TIF)

S2 Fig. SEC and SDS-PAGE of the Fab-MgtE complex.

(A) SEC of the MgtE-Fab complex. The former, middle, and latter peaks were the void, Fab-MgtE complex, and free Fab, respectively. The fractions from the 10.5 to 12.0 ml elution positions were pooled as the cryo-EM sample. (B) SDS-PAGE of the SEC fractions and the cryo-EM sample. The individual numerical values that underlie the summary data displayed in this figure can be found in S1 Data. cryo-EM, cryo-electron microscopy; SDS-PAGE, sodium dodecyl sulfate-polyacrylamide gel electrophoresis; SEC, size exclusion chromatography.

(TIF)

S3 Fig. Flowchart for cryo-EM data processing.

(A) Overview of the data processing workflow, including particle picking, classification, and 3D refinement. All processing steps were performed in RELION. (B) Euler angle distribution plot of all particles included in the calculation of the MgtE-Fab complex, with C2 symmetry imposed. cryo-EM, cryo-electron microscopy.

(TIF)

S4 Fig. EM density map.

(A–E) Representative EM density maps contoured at 4.0 σ. The TM1 helix (residues 278–311) (A), TM2 helix (residues 315–345) (B), TM3 helix (residues 353–380) (C), TM4 helix (residues 384–416) (D), and TM5 helix (residues 419–448) (E) in chain A are shown as stick representations. EM, electron microscopy; TM, transmembrane.

(TIF)

S5 Fig. EM map for the TM domain obtained by signal subtraction.

(A) Side view of the EM density map for the TM domain obtained by signal subtraction, colored according to local resolution, calculated using RELION. (B) Gold standard FSC for estimating resolution. The individual numerical values that underlie the summary data displayed in this figure can be found in S1 Data. EM, electron microscopy; FSC, Fourier shell correlation; TM, transmembrane.

(TIF)

S6 Fig. Fab binding site.

A close-up view of the MgtE-Fab interface on the cytoplasmic side (A) and of the corresponding region in full-length MgtE in the Mg2+-bound form (PDB ID: 2ZY9) (B). The coloring scheme of MgtE is the same as that in Fig 1, and Fab is colored gray. Residues located at the MgtE-Fab interface are depicted as stick representations. Mg2+ ions are depicted as purple spheres.

(TIF)

S7 Fig. Structural comparisons.

Superimpositions of our cryo-EM structure of the MgtE-Fab complex under Mg2+-free conditions and the Mg2+-free cytoplasmic domain structure (PDB ID: 2YVZ) onto full-length MgtE in the Mg2+-bound form (PDB ID: 2ZY9), viewed parallel to the membrane (A) and from the cytoplasmic side (B). The coloring scheme of the full-length MgtE structure is the same as that in Fig 1. The Mg2+-free cytoplasmic domain structure is colored gray. The TM domain and Fabs in the MgtE-Fab complex are colored red and orange, respectively. cryo-EM, cryo-electron microscopy; TM, transmembrane.

(TIF)

S8 Fig. MD simulations.

(A) Structural deviations from the Mg2+-free MgtE TM domain structure during the 3-μs MD simulations. (B–E) Cα distances between Thr336 (chain B) and Leu421 (chain A) (B), between Thr336 (chain A) and Leu421 (chain B) (C), between Ala317 (chains A and B) (D), and between Glu311 (chains A and B) (E) during the 3-μs MD simulation. The MD simulations were performed with (red) and without (black) adding Mg2+ ion at the Mg2+ binding site in the pore. The position of the added Mg2+ ion in the pore was based on the previous Mg2+-bound MgtE structure (PDB ID: 2ZY9) (Fig 1A). (F, G) The Mg2+-free MgtE TM domain structures after the 3-μs MD simulations with (G) and without (F) adding Mg2+ ion in the pore are superposed onto Mg2+-bound MgtE in the closed state (PDB ID:2ZY9) using the Cα positions of the TM domain dimer. The MgtE structures after the 3-μs MD simulations are colored salmon (chain A) and cyan (chain B). Mg2+-bound MgtE is colored gray. Mg2+ ions are shown as purple spheres. The black arrows indicate the structural changes. The individual numerical values that underlie the summary data displayed in this figure can be found in S1 Data. MD, molecular dynamics; TM, transmembrane.

(TIF)

S9 Fig. Cartoon diagram of Fab705 effect.

A cartoon of the proposed effect of Fab705 in the presence of Mg2+ (A) and under Mg2+-free conditions (B, C). Briefly, Fab705 cannot bind to MgtE at high Mg2+ concentrations (A). At low Mg2+ concentrations, Fab705 can bind to MgtE but does not either positively or negatively modulate channel opening, and a high concentration of Mg2+ ions can still close the MgtE channel by disrupting the MgtE-Fab complex (C).

(TIF)

S10 Fig. ITC profiles of MgtE with Fab705.

(A, B) ITC profiles of MgtE with Fab705 in the presence of 0 mM MgCl2 (A) and 20 mM MgCl2 (B). The individual numerical values that underlie the summary data displayed in this figure can be found in S1 Data. ITC, isothermal titration calorimetry.

(TIF)

S11 Fig. SDS-PAGE gels from chemical cross-linking experiments with the MgtE double cysteine mutant T336C/L421C.

SDS-PAGE, sodium dodecyl sulfate-polyacrylamide gel electrophoresis.

(TIF)

S12 Fig. Patch clamp recording of MgtE using E. coli giant spheroplasts.

(A) Representative current traces from the same patch of triple-knockout E. coli spheroplasts expressing MgtE under 0 mM MgCl2 (left) and under 20 mM MgCl2 (right) in the bath solution. Application of the bath solution containing 20 mM MgCl2 inhibited channel opening. Experiments were repeated 3 times, and similar results were obtained. (B) Representative current traces of triple-knockout E. coli spheroplasts expressing MgtE with multiple channel openings in the patch. Of the 18 patches, 14 of them showed channel currents, and 4 contained 2–4 channels. (C) Representative current traces from triple-knockout E. coli spheroplasts harboring the empty vector. Experiments were repeated 7 times, and no channel currents were obtained. The individual numerical values that underlie the summary data displayed in this figure can be found in S1 Data.

(TIF)

S13 Fig. Western blot of the MgtE N332A and N424A mutants.

(TIF)

S14 Fig. Western blot of the MgtE glycine mutants.

Uncropped western blots are provided in S1 Raw Images.

(TIF)

S1 Video. Structural changes in the MgtE TM domain.

TM, transmembrane.

(MP4)

S1 Table. ITC statistics.

ITC, isothermal titration calorimetry.

(PDF)

S2 Table. Cryo-EM data collection, refinement, and validation statistics.

cryo-EM, cryo-electron microscopy.

(PDF)

S1 Data. Numerical raw data.

All numerical raw data associated with Figs 1D–1H, 2C, 4C, and 5E and S2A, S5B, S8A–S8E, S10A, S10B, and S12A–S12C Figs. File contains multiple tabs with labels corresponding to the relevant figure.

(XLSX)

S1 Raw Images. Uncropped western blots from S14 Fig.

(TIF)

Acknowledgments

We thank the staff scientists at the Center for Biological Imaging, Institute of Biophysics, and National Center for Protein Science Shanghai (Chinese Academy of Sciences) for technical support with cryo-EM data collection (project numbers: CBIapp20180107, CBIapp201807006, CBIapp201807007, 2017-NFPS-PT-001632, and 2018-NFPS-PT-002187); Yumi Sato for technical assistance in the generation of antibodies; Namba Laboratory members for technical support with cryo-EM data collection; Dr. Hideaki E. Kato (University of Tokyo) for critical comments on the manuscript; and Drs. Chia-Hsueh Lee (St. Jude Children’s Research Hospital) and Muneyoshi Ichikawa (NAIST) for their technical advice on cryo-EM data processing.

Abbreviations

CBS

cystathionine-beta-synthase

cryo-EM

cryo-electron microscopy

CTF

contrast transfer function

DDM

n-dodecyl-beta-d-maltopyranoside

DTT

dithiothreitol

ELISA

enzyme-linked immunosorbent assay

FSC

Fourier shell correlation

FSEC

fluorescence detection size exclusion chromatography

HRV3C

human rhinovirus 3C

HS-AFM

high-speed atomic force microscopy

IPTG

isopropyl-β-D-thiogalactoside

ITC

isothermal titration calorimetry

MD

molecular dynamics

PBC

periodic boundary condition

PMSF

phenylmethanesulfonyl fluoride

POPC

phosphoryl-oleoyl phosphatidylcholine

SDS-PAGE

sodium dodecyl sulfate-polyacrylamide gel electrophoresis

SEC

size exclusion chromatography

SPC

simple point charge; TM, transmembrane

Data Availability

All raw data for the Figures presented in the manuscript can be found in the Supplementary Information. The atomic coordinates and structural factors of the MgtE-Fab structure were deposited in the Protein Data Bank. The accession numbers for the MgtE-Fab structure are PDB: 6LBH and EMD: EMDB-0869 (https://www.ebi.ac.uk/pdbe/entry/emdb/EMDB-0869).

Funding Statement

This work was supported by funding from the Ministry of Science and Technology of China (National Key R&D Program of China: 2016YFA0502800) to M.H.; funding from the National Natural Science Foundation of China (32071234) to M.H., the Innovative Research Team of High-level Local Universities in Shanghai and a key laboratory program of the Education Commission of Shanghai Municipality (ZDSYS14005); grants from Basis for Supporting Innovative Drug Discovery and Life Science Research (BINDS) from the Japan Agency of Medical Research and Development (AMED) (grant no. 19am0101079; Support No. 0451); Research on Development of New Drugs from the AMED; and Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (JSPS) (nos. 18K05334 and 19H00923). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Hartwig A. Role of magnesium in genomic stability. Mutat Res Mol Mech Mutagen. 2001;475:113–21. 10.1016/s0027-5107(01)00074-4 [DOI] [PubMed] [Google Scholar]
  • 2.Cowan JA. Structural and catalytic chemistry of magnesium-dependent enzymes. Biometals. 2002;15: 225–35. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12206389. 10.1023/a:1016022730880 [DOI] [PubMed] [Google Scholar]
  • 3.Maguire ME, Cowan JA. Magnesium chemistry and biochemistry. Biometals. 2002;15:203–10. 10.1023/a:1016058229972 [DOI] [PubMed] [Google Scholar]
  • 4.Alexander RT, Hoenderop JG, Bindels RJ. Molecular determinants of magnesium homeostasis: insights from human disease. J Am Soc Nephrol. 2008;19:1451–8. 10.1681/ASN.2008010098 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Groisman EA, Hollands K, Kriner MA, Lee E-J, Park S-Y, Pontes MH. Bacterial Mg2+ homeostasis, transport, and virulence. Annu Rev Genet. 2013;47:625–46. 10.1146/annurev-genet-051313-051025 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Romani AMP. Cellular magnesium homeostasis. Arch Biochem Biophys. 2011;512:1–23. 10.1016/j.abb.2011.05.010 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Moomaw AS, Maguire ME. The unique nature of mg2+ channels. Physiology (Bethesda). 2008;23:275–85. 10.1152/physiol.00019.2008 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Smith RL, Thompson LJ, Maguire ME. Cloning and characterization of MgtE, a putative new class of Mg2+ transporter from Bacillus firmus OF4. J Bacteriol. 1995;177:1233–8. 10.1128/jb.177.5.1233-1238.1995 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Townsend DE, Esenwine AJ, George J, Bross D, Maguire ME, Smith RL. Cloning of the mgtE Mg2+ transporter from Providencia stuartii and the distribution of mgtE in gram-negative and gram-positive bacteria. J Bacteriol. 1995;177:5350–4. 10.1128/jb.177.18.5350-5354.1995 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Goytain A, Quamme GA. Functional characterization of human SLC41A1, a Mg2+ transporter with similarity to prokaryotic MgtE Mg2+ transporters. Physiol Genomics. 2005;21:337–42. 10.1152/physiolgenomics.00261.2004 [DOI] [PubMed] [Google Scholar]
  • 11.Sahni J, Scharenberg AM. The SLC41 family of MgtE-like magnesium transporters. Mol Asp Med. 2013;34:620–8. 10.1016/j.mam.2012.05.012 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Schweigel-Röntgen M, Kolisek M. SLC41 Transporters—Molecular Identification and Functional Role. Curr Top Membr. 2014:383–410. 10.1016/B978-0-12-800223-0.00011-6 [DOI] [PubMed] [Google Scholar]
  • 13.Dann CE, Wakeman CA, Sieling CL, Baker SC, Irnov I, Winkler WC. Structure and mechanism of a metal-sensing regulatory RNA. Cell. 2007;130:878–92. 10.1016/j.cell.2007.06.051 [DOI] [PubMed] [Google Scholar]
  • 14.Hattori M, Iwase N, Furuya N, Tanaka Y, Tsukazaki T, Ishitani R, et al. Mg2+-dependent gating of bacterial MgtE channel underlies Mg2+ homeostasis. EMBO J. 2009;28:3602–12. 10.1038/emboj.2009.288 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Lee D-YD, Galera-Laporta L, Bialecka-Fornal M, Moon EC, Shen Z, Briggs SP, et al. Magnesium Flux Modulates Ribosomes to Increase Bacterial Survival. Cell. 2019;177:352–60.e13. 10.1016/j.cell.2019.01.042 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Takeda H, Hattori M, Nishizawa T, Yamashita K, Shah STA, Caffrey M, et al. Structural basis for ion selectivity revealed by high-resolution crystal structure of Mg2+ channel MgtE. Nat Commun. 2014;5:5374. 10.1038/ncomms6374 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Tomita A, Zhang M, Jin F, Zhuang W, Takeda H, Maruyama T, et al. ATP-dependent modulation of MgtE in Mg2+ homeostasis. Nat Commun. 2017;8:148. 10.1038/s41467-017-00082-w [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Mandt T, Song Y, Scharenberg AM, Sahni J. SLC41A1 Mg2+ transport is regulated via Mg2+-dependent endosomal recycling through its N-terminal cytoplasmic domain. Biochem J. 2011;439:129–39. 10.1042/BJ20110807 [DOI] [PubMed] [Google Scholar]
  • 19.Sahni J, Nelson B, Scharenberg AM. SLC41A2 encodes a plasma-membrane Mg2+ transporter. Biochem J. 2007;401:505–13. 10.1042/BJ20060673 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.de Baaij JHF, Arjona FJ, van den Brand M, Lavrijsen M, Lameris ALL, Bindels RJM, et al. Identification of SLC41A3 as a novel player in magnesium homeostasis. Sci Rep. 2016;6:28565. 10.1038/srep28565 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Chan KHK, Chacko SA, Song Y, Cho M, Eaton CB, Wu W-CH, et al. Genetic variations in magnesium-related ion channels may affect diabetes risk among African American and Hispanic American women. J Nutr. 2015;145:418–24. 10.3945/jn.114.203489 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Kolisek M, Sponder G, Mastrototaro L, Smorodchenko A, Launay P, Vormann J, et al. Substitution p.A350V in Na+/Mg2+ exchanger SLC41A1, potentially associated with Parkinson’s disease, is a gain-of-function mutation. PLoS ONE. 2013;8:e71096. 10.1371/journal.pone.0071096 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Hurd TW, Otto EA, Mishima E, Gee HY, Inoue H, Inazu M, et al. Mutation of the Mg2+ transporter SLC41A1 results in a nephronophthisis-like phenotype. J Am Soc Nephrol. 2013;24:967–77. 10.1681/ASN.2012101034 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Kolisek M, Nestler A, Vormann J, Schweigel-Röntgen M. Human gene SLC41A1 encodes for the Na+/Mg2+ exchanger. Am J Physiol Physiol. 2012;302:C318–26. 10.1152/ajpcell.00289.2011 [DOI] [PubMed] [Google Scholar]
  • 25.Picollo A, Pusch M. Chloride/proton antiporter activity of mammalian CLC proteins ClC-4 and ClC-5. Nature. 2005;436:420–3. 10.1038/nature03720 [DOI] [PubMed] [Google Scholar]
  • 26.Scheel O, Zdebik AA, Lourdel S, Jentsch TJ. Voltage-dependent electrogenic chloride/proton exchange by endosomal CLC proteins. Nature. 2005;436:424–7. 10.1038/nature03860 [DOI] [PubMed] [Google Scholar]
  • 27.Accardi A, Miller C. Secondary active transport mediated by a prokaryotic homologue of ClC Cl- channels. Nature. 2004;427:803–7. 10.1038/nature02314 [DOI] [PubMed] [Google Scholar]
  • 28.Jentsch TJ, Steinmeyer K, Schwarz G. Primary structure of Torpedo marmorata chloride channel isolated by expression cloning in Xenopus oocytes. Nature. 1990;348:510–4. 10.1038/348510a0 [DOI] [PubMed] [Google Scholar]
  • 29.Miller C, White MM. Dimeric structure of single chloride channels from Torpedo electroplax. Proc Natl Acad Sci U S A. 1984;81:2772–5. 10.1073/pnas.81.9.2772 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Hattori M, Tanaka Y, Fukai S, Ishitani R, Nureki O. Crystal structure of the MgtE Mg2+ transporter. Nature. 2007;448:1072–5. 10.1038/nature06093 [DOI] [PubMed] [Google Scholar]
  • 31.Ishitani R, Sugita Y, Dohmae N, Furuya N, Hattori M, Nureki O. Mg2+-sensing mechanism of Mg2+ transporter MgtE probed by molecular dynamics study. Proc Natl Acad Sci U S A. 2008;105:15393–8. 10.1073/pnas.0802991105 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Haruyama T, Sugano Y, Kodera N, Uchihashi T, Ando T, Tanaka Y. Single-Unit Imaging of Membrane Protein- Embedded Nanodiscs from Two Oriented Sides by Resource Single-Unit Imaging of Membrane Protein-Embedded Nanodiscs from Two Oriented Sides by High-Speed Atomic Force Microscopy. Structure. 2019;27:152–60.e3. 10.1016/j.str.2018.09.005 [DOI] [PubMed] [Google Scholar]
  • 33.Lü W, Du J, Goehring A, Gouaux E. Cryo-EM structures of the triheteromeric NMDA receptor and its allosteric modulation. Science. 2017;355:eaal3729. 10.1126/science.aal3729 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Park E, Campbell EB, MacKinnon R. Structure of a CLC chloride ion channel by cryo-electron microscopy. Nature. 2017;541:500–5. 10.1038/nature20812 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Manolaridis I, Jackson SM, Taylor NMI, Kowal J, Stahlberg H, Locher KP. Cryo-EM structures of a human ABCG2 mutant trapped in ATP-bound and substrate-bound states. Nature. 2018;563:426–30. 10.1038/s41586-018-0680-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Butterwick JA, Del Mármol J, Kim KH, Kahlson MA, Rogow JA, Walz T, et al. Cryo-EM structure of the insect olfactory receptor Orco. Nature. 2018;560:447–52. 10.1038/s41586-018-0420-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Coleman JA, Yang D, Zhao Z, Wen P-C, Yoshioka C, Tajkhorshid E, et al. Serotonin transporter–ibogaine complexes illuminate mechanisms of inhibition and transport. Nature. 2019;569:141–5. 10.1038/s41586-019-1135-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Matthies D, Dalmas O, Borgnia MJ, Dominik PK, Merk A, Rao P, et al. Cryo-EM Structures of the Magnesium Channel CorA Reveal Symmetry Break upon Gating. Cell. 2016;164:747–56. 10.1016/j.cell.2015.12.055 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Sikkema HR, van den Noort M, Rheinberger J, de Boer M, Krepel ST, Schuurman-Wolters GK, et al. Gating by ionic strength and safety check by cyclic-di-AMP in the ABC transporter OpuA. Sci Adv. 2020;6. 10.1126/sciadv.abd7697 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Zheng SQ, Palovcak E, Armache J-P, Verba KA, Cheng Y, Agard DA. MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy. Nat Methods. 2017;14:331–2. 10.1038/nmeth.4193 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Rohou A, Grigorieff N. CTFFIND4: Fast and accurate defocus estimation from electron micrographs. J Struct Biol. 2015;192:216–21. 10.1016/j.jsb.2015.08.008 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Zivanov J, Nakane T, Forsberg BO, Kimanius D, Hagen WJ, Lindahl E, et al. New tools for automated high-resolution cryo-EM structure determination in RELION-3. Elife. 2018;7. 10.7554/eLife.42166 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Biasini M, Bienert S, Waterhouse A, Arnold K, Studer G, Schmidt T, et al. SWISS-MODEL: modelling protein tertiary and quaternary structure using evolutionary information. Nucleic Acids Res. 2014;42:W252–8. 10.1093/nar/gku340 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Emsley P, Lohkamp B, Scott WG, Cowtan K. Features and development of Coot. Acta Crystallogr Sect D Biol Crystallogr. 2010;66:486–501. 10.1107/S0907444910007493 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Afonine PV, Grosse-Kunstleve RW, Echols N, Headd JJ, Moriarty NW, Mustyakimov M, et al. Towards automated crystallographic structure refinement with phenix refine. Acta Crystallogr D Biol Crystallogr. 2012;68:352–67. 10.1107/S0907444912001308 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Sievers F, Higgins DG. Clustal Omega for making accurate alignments of many protein sequences. Protein Sci. 2018;27;135–45. 10.1002/pro.3290 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Robert X, Gouet P. Deciphering key features in protein structures with the new ENDscript server. Nucleic Acids Res. 2014;42:W320–4. 10.1093/nar/gku316 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Smart OS, Neduvelil JG, Wang X, Wallace BA, Sansom MS. HOLE: a program for the analysis of the pore dimensions of ion channel structural models. J Mol Graph. 1996;14: 354–360,376. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9195488. 10.1016/s0263-7855(97)00009-x [DOI] [PubMed] [Google Scholar]
  • 49.Jaenecke F, Nakada-Nakura Y, Nagarathinam K, Ogasawara S, Liu K, Hotta Y, et al. Generation of Conformation-Specific Antibody Fragments for Crystallization of the Multidrug Resistance Transporter MdfA. Methods Mol Biol. 2018;1700:97–109. 10.1007/978-1-4939-7454-2_7_7 [DOI] [PubMed] [Google Scholar]
  • 50.Köhler G. Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature. 1975;256:495–7. 10.1038/256495a0 [DOI] [PubMed] [Google Scholar]
  • 51.Wang J, Wang Y, Cui W-W, Huang Y, Yang Y, Liu Y, et al. Druggable negative allosteric site of P2X3 receptors. Proc Natl Acad Sci U S A. 2018;115:4939–44. 10.1073/pnas.1800907115 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Li B, Wang J, Cheng X, Liu Y, Yang Y, Yang X, et al. Molecular mechanism underlying the subtype-selectivity of competitive inhibitor NF110 and its distinct potencies in human and rat P2X3 receptors. Sci Bull. 2018;63:1616–25. 10.1016/j.scib.2018.11.016 [DOI] [PubMed] [Google Scholar]
  • 53.Shaw DE. A fast, scalable method for the parallel evaluation of distance-limited pairwise particle interactions. J Comput Chem. 2005;26:1318–28. 10.1002/jcc.20267 [DOI] [PubMed] [Google Scholar]
  • 54.Kaminski GA, Friesner RA, Tirado-Rives J, Jorgensen WL. Evaluation and Reparametrization of the OPLS-AA Force Field for Proteins via Comparison with Accurate Quantum Chemical Calculations on Peptides. J Phys Chem B. 2001;105:6474–87. 10.1021/jp003919d [DOI] [Google Scholar]
  • 55.Jorgensen WL, Maxwell DS, Tirado-Rives J. Development and Testing of the OPLS All-Atom Force Field on Conformational Energetics and Properties of Organic Liquids. J Am Chem Soc. 1996;118:11225–36. 10.1021/ja9621760 [DOI] [Google Scholar]
  • 56.Martinac B, Buechner M, Delcour AH, Adler J, Kung C. Pressure-sensitive ion channel in Escherichia coli. Proc Natl Acad Sci U S A. 1987;84: 2297–301. Available from: http://www.ncbi.nlm.nih.gov/pubmed/2436228. 10.1073/pnas.84.8.2297 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Richard Hodge

25 Nov 2020

Dear Dr Hattori,

Thank you for submitting your manuscript entitled "Cryo-EM structure of the MgtE Mg2+ channel pore domain in Mg2+-free conditions reveals cytoplasmic pore opening" for consideration as a Research Article by PLOS Biology.

Your manuscript has now been evaluated by the PLOS Biology editorial staff as well as by an academic editor with relevant expertise and I am writing to let you know that we would like to pursue your manuscript further and invite you to submit a revised version of the manuscript.

However, before we can invite a revision, we need you to complete your submission by providing the metadata that is required for full assessment. To this end, please login to Editorial Manager where you will find the paper in the 'Submissions Needing Revisions' folder on your homepage. Please click 'Revise Submission' from the Action Links and complete all additional questions in the submission questionnaire.

Please re-submit your manuscript within two working days, i.e. by Nov 27 2020 11:59PM.

Login to Editorial Manager here: https://www.editorialmanager.com/pbiology

During resubmission, you will be invited to opt-in to posting your pre-review manuscript as a bioRxiv preprint. Visit http://journals.plos.org/plosbiology/s/preprints for full details. If you consent to posting your current manuscript as a preprint, please upload a single Preprint PDF when you re-submit.

Feel free to email us at plosbiology@plos.org if you have any queries relating to your submission.

Kind regards,

Richard Hodge, PhD

Associate Editor

PLOS Biology

Decision Letter 1

Richard Hodge

26 Nov 2020

Dear Dr Hattori,

Thank you very much for submitting your manuscript "Cryo-EM structure of the MgtE Mg2+ channel pore domain in Mg2+ -free conditions reveals cytoplasmic pore opening" for consideration as a Research Article at PLOS Biology.

As you know, your manuscript and plan of revision have been evaluated by the PLOS Biology editors and by an Academic Editor with relevant expertise.

Based on your responses to the reviews from Reviews Commons, we would welcome re-submission of a revised version that takes into account the reviewers' comments. In addition, the Academic Editor would like you to provide a clear response to Reviewer #2 comments in the manuscript that clarifies the function of MgtE as an ion channel or a secondary active transporter.

In addition, the Academic Editor requests that you provide additional reporting details regarding the electrophysiology experiments conducted in the manuscript. We ask whether you have recorded macroscopic currents and whether a similar channel behaviour is seen. We would also like you to clarify in the manuscript whether you have recorded current-voltage relationships in asymmetric Mg2+ concentrations and assess Mg2+ selectivity based on the analysis of reversal potentials. In both cases, it would be acceptable to discuss and refer to this data by citing previous publications.

We cannot make any decision about publication until we have seen the revised manuscript and your response to the reviewers' comments. Your revised manuscript is also likely to be sent for further evaluation by the original reviewers.

We expect to receive your revised manuscript within 3 months. Please email us (plosbiology@plos.org) if you have any questions or concerns, or would like to request an extension. At this stage, your manuscript remains formally under active consideration at our journal; please notify us by email if you do not intend to submit a revision so that we may end consideration of the manuscript at PLOS Biology.

Your revisions should address the specific points made by each reviewer. Please submit the following files along with your revised manuscript:

1. A 'Response to Reviewers' file - this should detail your responses to the editorial requests, present a point-by-point response to all of the reviewers' comments, and indicate the changes made to the manuscript.

*NOTE: In your point by point response to the reviewers, please provide the full context of each review. Do not selectively quote paragraphs or sentences to reply to. The entire set of reviewer comments should be present in full and each specific point should be responded to individually, point by point.

You should also cite any additional relevant literature that has been published since the original submission and mention any additional citations in your response.

2. In addition to a clean copy of the manuscript, please also upload a 'track-changes' version of your manuscript that specifies the edits made. This should be uploaded as a "Related" file type.

*Re-submission Checklist*

When you are ready to resubmit your revised manuscript, please refer to this re-submission checklist: https://plos.io/Biology_Checklist

To submit a revised version of your manuscript, please go to https://www.editorialmanager.com/pbiology/ and log in as an Author. Click the link labelled 'Submissions Needing Revision' where you will find your submission record.

Please make sure to read the following important policies and guidelines while preparing your revision:

*Published Peer Review*

Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out. Please see here for more details:

https://blogs.plos.org/plos/2019/05/plos-journals-now-open-for-published-peer-review/

*PLOS Data Policy*

Please note that as a condition of publication PLOS' data policy (http://journals.plos.org/plosbiology/s/data-availability) requires that you make available all data used to draw the conclusions arrived at in your manuscript. If you have not already done so, you must include any data used in your manuscript either in appropriate repositories, within the body of the manuscript, or as supporting information (N.B. this includes any numerical values that were used to generate graphs, histograms etc.). For an example see here: http://www.plosbiology.org/article/info%3Adoi%2F10.1371%2Fjournal.pbio.1001908#s5

*Blot and Gel Data Policy*

We require the original, uncropped and minimally adjusted images supporting all blot and gel results reported in an article's figures or Supporting Information files. We will require these files before a manuscript can be accepted so please prepare them now, if you have not already uploaded them. Please carefully read our guidelines for how to prepare and upload this data: https://journals.plos.org/plosbiology/s/figures#loc-blot-and-gel-reporting-requirements

*Protocols deposition*

To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosbiology/s/submission-guidelines#loc-materials-and-methods

Thank you again for your submission to our journal. We hope that our editorial process has been constructive thus far, and we welcome your feedback at any time. Please don't hesitate to contact us if you have any questions or comments.

Sincerely,

Richard Hodge, PhD

Associate Editor

PLOS Biology

Decision Letter 2

Richard Hodge

24 Mar 2021

Dear Dr Hattori,

Thank you for submitting your revised Research Article entitled "Cryo-EM structure of the MgtE Mg2+ channel pore domain:Fab complex in Mg2+-free conditions reveals cytoplasmic pore opening" for publication in PLOS Biology. I have now obtained advice from the original reviewers and have discussed their comments with the Academic Editor.

Based on the reviews (attached below), we will probably accept this manuscript for publication, provided you satisfactorily address the remaining points raised by the reviewers. Please also make sure to address the following data and other policy-related requests:

a) We ask that you please take into account the concerns of Reviewer #2 and soften the claims on the nature of MgtE as an ion channel in your revised manuscript. Please re-phrase your wording in the discussion section (e.g. ‘the data is most consistent with the protein acting as an ion channel’).

b) We would like you to consider a suggestion to improve the title as follows:

"The structure of MgtE in the absence of magnesium provides new insights into channel gating”

As you address these items, please take this last chance to review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the cover letter that accompanies your revised manuscript.

We expect to receive your revised manuscript within two weeks.

To submit your revision, please go to https://www.editorialmanager.com/pbiology/ and log in as an Author. Click the link labelled 'Submissions Needing Revision' to find your submission record. Your revised submission must include the following:

- a cover letter that should detail your responses to any editorial requests, if applicable, and whether changes have been made to the reference list.

NOTE: If Supporting Information files are included with your article, note that these are not copyedited and will be published as they are submitted. Please ensure that these files are legible and of high quality (at least 300 dpi) in an easily accessible file format. For this reason, please be aware that any references listed in an SI file will not be indexed. For more information, see our Supporting Information guidelines:

https://journals.plos.org/plosbiology/s/supporting-information

*Published Peer Review History*

Please note that you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out. Please see here for more details:

https://blogs.plos.org/plos/2019/05/plos-journals-now-open-for-published-peer-review/

*Early Version*

Please note that an uncorrected proof of your manuscript will be published online ahead of the final version, unless you opted out when submitting your manuscript. If, for any reason, you do not want an earlier version of your manuscript published online, uncheck the box. Should you, your institution's press office or the journal office choose to press release your paper, you will automatically be opted out of early publication. We ask that you notify us as soon as possible if you or your institution is planning to press release the article.

*Protocols deposition*

To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols

Please do not hesitate to contact me should you have any questions.

Sincerely,

Richard

Richard Hodge, PhD

Associate Editor, PLOS Biology

rhodge@plos.org

------------------------------------------------------------------------

DATA POLICY: IMPORTANT - PLEASE READ

You may be aware of the PLOS Data Policy, which requires that all data be made available without restriction: http://journals.plos.org/plosbiology/s/data-availability. For more information, please also see this editorial: http://dx.doi.org/10.1371/journal.pbio.1001797

Note that we do not require all raw data. Rather, we ask that all individual quantitative observations that underlie the data summarized in the figures and results of your paper be made available in one of the following forms:

1) Supplementary files (e.g., excel). Please ensure that all data files are uploaded as 'Supporting Information' and are invariably referred to (in the manuscript, figure legends, and the Description field when uploading your files) using the following format verbatim: S1 Data, S2 Data, etc. Multiple panels of a single or even several figures can be included as multiple sheets in one excel file that is saved using exactly the following convention: S1_Data.xlsx (using an underscore).

2) Deposition in a publicly available repository.

Regardless of the method selected, please ensure that you provide the individual numerical values that underlie the summary data displayed in the following figure panels as they are essential for readers to assess your analysis and to reproduce it:

Fig. 1D-H; Fig. 2C; Fig. 4C; Fig. 5E; Fig. S2A; Fig. S5B, Fig. S8A-E, Fig. S10A, B and S12

NOTE: the numerical data provided should include all replicates AND the way in which the plotted mean and errors were derived (it should not present only the mean/average values).

*Please also ensure that figure legends in your manuscript include information on WHERE THE UNDERLYING DATA CAN BE FOUND where the underlying data can be found, and ensure your supplemental data file/s has a legend*

Please ensure that your Data Statement in the submission system accurately describes where your data can be found. In your revised submission, please delete the following sentence in the ‘Additional data availability information’ box:

‘Tick here if the URLs/accession numbers/DOIs will be available only after acceptance of the manuscript for publication so that we can ensure their inclusion before publication.’

* Please also make the structural data deposited in the PDB (6LBH) and EMD (EMDB-0869) publicly available.

-------------------------------------------------------------------------

BLOT AND GEL REPORTING REQUIREMENTS:

For manuscripts submitted on or after 1st July 2019, we require the original, uncropped and minimally adjusted images supporting all blot and gel results reported in an article's figures or Supporting Information files. We will require these files before a manuscript can be accepted so please prepare and upload them now. Please carefully read our guidelines for how to prepare and upload this data: https://journals.plos.org/plosbiology/s/figures#loc-blot-and-gel-reporting-requirements

------------------------------------------------------------------------

Reviewer remarks:

Reviewer #1: The authors have address my concerns. I have no further comments on the manuscript.

Reviewer #2: Overall, I am satisfied with the revised version of the paper. I am still not convinced that MgtE is a channel, but on the balance of it, I think its more likely to be a channel than a secondary-active transporter. I think the authors have made their scientific arguments clearer and their data will no doubt contribute to a clearer function of this protein.

Decision Letter 3

Richard Hodge

12 Apr 2021

Dear Dr Hattori,

On behalf of my colleagues and the Academic Editor, Raimund Dutzler, I am pleased to say that we can in principle offer to publish your Research Article "The structure of MgtE in the absence of magnesium provides new insights into channel gating" in PLOS Biology, provided you address any remaining formatting and reporting issues. These will be detailed in an email that will follow this letter and that you will usually receive within 2-3 business days, during which time no action is required from you. Please note that we will not be able to formally accept your manuscript and schedule it for publication until you have made the required changes.

Please take a minute to log into Editorial Manager at http://www.editorialmanager.com/pbiology/, click the "Update My Information" link at the top of the page, and update your user information to ensure an efficient production process.

PRESS

We frequently collaborate with press offices. If your institution or institutions have a press office, please notify them about your upcoming paper at this point, to enable them to help maximise its impact. If the press office is planning to promote your findings, we would be grateful if they could coordinate with biologypress@plos.org. If you have not yet opted out of the early version process, we ask that you notify us immediately of any press plans so that we may do so on your behalf.

We also ask that you take this opportunity to read our Embargo Policy regarding the discussion, promotion and media coverage of work that is yet to be published by PLOS. As your manuscript is not yet published, it is bound by the conditions of our Embargo Policy. Please be aware that this policy is in place both to ensure that any press coverage of your article is fully substantiated and to provide a direct link between such coverage and the published work. For full details of our Embargo Policy, please visit http://www.plos.org/about/media-inquiries/embargo-policy/.

Thank you again for supporting Open Access publishing. We look forward to publishing your paper in PLOS Biology. 

Sincerely, 

Richard

Richard Hodge, PhD

Associate Editor, PLOS Biology

rhodge@plos.org

PLOS

Empowering researchers to transform science

Carlyle House, Carlyle Road, Cambridge, CB4 3DN, United Kingdom

California (U.S.) corporation #C2354500, based in San Francisco

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Fig. FSEC analysis of MgtE-Fab complex formation.

    (A, B) FSEC analysis of MgtE-Fab complex formation. The MgtE-Fab complex was formed by adding Fab to MgtE in 0 mM MgCl2 (A) and in 20 mM MgCl2 (B) at the indicated mass ratios. The FSEC running buffer included 0 mM for (A) and 20 mM MgCl2 for (B). (C) The complex disruption experiment was performed by adding Mg2+ at a final concentration of 20 mM to the preformed MgtE-Fab complex, which was prepared by mixing MgtE and Fab705 at a mass ratio of 1:2 in 0 mM Mg2+. In addition to the FSEC profile for the complex disrupted sample (blue), the FSEC profiles of Fab-free MgtE in Mg2+-free conditions (orange) and 20 mM MgCl2 (gray) are also shown. The FSEC running buffer includes 20 mM MgCl2, except for the FSEC of MgtE in Mg2+-free conditions. In FSEC profiles, Mg2+-free MgtE (A, C) eluted earlier than Mg2+-bound MgtE (B, C), probably because the conformation of MgtE, in particular the conformation of the cytoplasmic domain of MgtE, is more compact in the presence of Mg2+ than in the absence of Mg2+ as shown in Fig 1B. FSEC, fluorescence detection size exclusion chromatography.

    (TIF)

    S2 Fig. SEC and SDS-PAGE of the Fab-MgtE complex.

    (A) SEC of the MgtE-Fab complex. The former, middle, and latter peaks were the void, Fab-MgtE complex, and free Fab, respectively. The fractions from the 10.5 to 12.0 ml elution positions were pooled as the cryo-EM sample. (B) SDS-PAGE of the SEC fractions and the cryo-EM sample. The individual numerical values that underlie the summary data displayed in this figure can be found in S1 Data. cryo-EM, cryo-electron microscopy; SDS-PAGE, sodium dodecyl sulfate-polyacrylamide gel electrophoresis; SEC, size exclusion chromatography.

    (TIF)

    S3 Fig. Flowchart for cryo-EM data processing.

    (A) Overview of the data processing workflow, including particle picking, classification, and 3D refinement. All processing steps were performed in RELION. (B) Euler angle distribution plot of all particles included in the calculation of the MgtE-Fab complex, with C2 symmetry imposed. cryo-EM, cryo-electron microscopy.

    (TIF)

    S4 Fig. EM density map.

    (A–E) Representative EM density maps contoured at 4.0 σ. The TM1 helix (residues 278–311) (A), TM2 helix (residues 315–345) (B), TM3 helix (residues 353–380) (C), TM4 helix (residues 384–416) (D), and TM5 helix (residues 419–448) (E) in chain A are shown as stick representations. EM, electron microscopy; TM, transmembrane.

    (TIF)

    S5 Fig. EM map for the TM domain obtained by signal subtraction.

    (A) Side view of the EM density map for the TM domain obtained by signal subtraction, colored according to local resolution, calculated using RELION. (B) Gold standard FSC for estimating resolution. The individual numerical values that underlie the summary data displayed in this figure can be found in S1 Data. EM, electron microscopy; FSC, Fourier shell correlation; TM, transmembrane.

    (TIF)

    S6 Fig. Fab binding site.

    A close-up view of the MgtE-Fab interface on the cytoplasmic side (A) and of the corresponding region in full-length MgtE in the Mg2+-bound form (PDB ID: 2ZY9) (B). The coloring scheme of MgtE is the same as that in Fig 1, and Fab is colored gray. Residues located at the MgtE-Fab interface are depicted as stick representations. Mg2+ ions are depicted as purple spheres.

    (TIF)

    S7 Fig. Structural comparisons.

    Superimpositions of our cryo-EM structure of the MgtE-Fab complex under Mg2+-free conditions and the Mg2+-free cytoplasmic domain structure (PDB ID: 2YVZ) onto full-length MgtE in the Mg2+-bound form (PDB ID: 2ZY9), viewed parallel to the membrane (A) and from the cytoplasmic side (B). The coloring scheme of the full-length MgtE structure is the same as that in Fig 1. The Mg2+-free cytoplasmic domain structure is colored gray. The TM domain and Fabs in the MgtE-Fab complex are colored red and orange, respectively. cryo-EM, cryo-electron microscopy; TM, transmembrane.

    (TIF)

    S8 Fig. MD simulations.

    (A) Structural deviations from the Mg2+-free MgtE TM domain structure during the 3-μs MD simulations. (B–E) Cα distances between Thr336 (chain B) and Leu421 (chain A) (B), between Thr336 (chain A) and Leu421 (chain B) (C), between Ala317 (chains A and B) (D), and between Glu311 (chains A and B) (E) during the 3-μs MD simulation. The MD simulations were performed with (red) and without (black) adding Mg2+ ion at the Mg2+ binding site in the pore. The position of the added Mg2+ ion in the pore was based on the previous Mg2+-bound MgtE structure (PDB ID: 2ZY9) (Fig 1A). (F, G) The Mg2+-free MgtE TM domain structures after the 3-μs MD simulations with (G) and without (F) adding Mg2+ ion in the pore are superposed onto Mg2+-bound MgtE in the closed state (PDB ID:2ZY9) using the Cα positions of the TM domain dimer. The MgtE structures after the 3-μs MD simulations are colored salmon (chain A) and cyan (chain B). Mg2+-bound MgtE is colored gray. Mg2+ ions are shown as purple spheres. The black arrows indicate the structural changes. The individual numerical values that underlie the summary data displayed in this figure can be found in S1 Data. MD, molecular dynamics; TM, transmembrane.

    (TIF)

    S9 Fig. Cartoon diagram of Fab705 effect.

    A cartoon of the proposed effect of Fab705 in the presence of Mg2+ (A) and under Mg2+-free conditions (B, C). Briefly, Fab705 cannot bind to MgtE at high Mg2+ concentrations (A). At low Mg2+ concentrations, Fab705 can bind to MgtE but does not either positively or negatively modulate channel opening, and a high concentration of Mg2+ ions can still close the MgtE channel by disrupting the MgtE-Fab complex (C).

    (TIF)

    S10 Fig. ITC profiles of MgtE with Fab705.

    (A, B) ITC profiles of MgtE with Fab705 in the presence of 0 mM MgCl2 (A) and 20 mM MgCl2 (B). The individual numerical values that underlie the summary data displayed in this figure can be found in S1 Data. ITC, isothermal titration calorimetry.

    (TIF)

    S11 Fig. SDS-PAGE gels from chemical cross-linking experiments with the MgtE double cysteine mutant T336C/L421C.

    SDS-PAGE, sodium dodecyl sulfate-polyacrylamide gel electrophoresis.

    (TIF)

    S12 Fig. Patch clamp recording of MgtE using E. coli giant spheroplasts.

    (A) Representative current traces from the same patch of triple-knockout E. coli spheroplasts expressing MgtE under 0 mM MgCl2 (left) and under 20 mM MgCl2 (right) in the bath solution. Application of the bath solution containing 20 mM MgCl2 inhibited channel opening. Experiments were repeated 3 times, and similar results were obtained. (B) Representative current traces of triple-knockout E. coli spheroplasts expressing MgtE with multiple channel openings in the patch. Of the 18 patches, 14 of them showed channel currents, and 4 contained 2–4 channels. (C) Representative current traces from triple-knockout E. coli spheroplasts harboring the empty vector. Experiments were repeated 7 times, and no channel currents were obtained. The individual numerical values that underlie the summary data displayed in this figure can be found in S1 Data.

    (TIF)

    S13 Fig. Western blot of the MgtE N332A and N424A mutants.

    (TIF)

    S14 Fig. Western blot of the MgtE glycine mutants.

    Uncropped western blots are provided in S1 Raw Images.

    (TIF)

    S1 Video. Structural changes in the MgtE TM domain.

    TM, transmembrane.

    (MP4)

    S1 Table. ITC statistics.

    ITC, isothermal titration calorimetry.

    (PDF)

    S2 Table. Cryo-EM data collection, refinement, and validation statistics.

    cryo-EM, cryo-electron microscopy.

    (PDF)

    S1 Data. Numerical raw data.

    All numerical raw data associated with Figs 1D–1H, 2C, 4C, and 5E and S2A, S5B, S8A–S8E, S10A, S10B, and S12A–S12C Figs. File contains multiple tabs with labels corresponding to the relevant figure.

    (XLSX)

    S1 Raw Images. Uncropped western blots from S14 Fig.

    (TIF)

    Attachment

    Submitted filename: 110112_1_rebuttal_1913662_qjml87.docx

    Attachment

    Submitted filename: 110112_1_rebuttal_1913662_qjml87.docx

    Attachment

    Submitted filename: Response-to-Reviewers-MgtE-PloSBio-Rev1.docx

    Attachment

    Submitted filename: Response-To-Reviewers-MgtE-PloSBio-Rev2.docx

    Data Availability Statement

    All raw data for the Figures presented in the manuscript can be found in the Supplementary Information. The atomic coordinates and structural factors of the MgtE-Fab structure were deposited in the Protein Data Bank. The accession numbers for the MgtE-Fab structure are PDB: 6LBH and EMD: EMDB-0869 (https://www.ebi.ac.uk/pdbe/entry/emdb/EMDB-0869).


    Articles from PLoS Biology are provided here courtesy of PLOS

    RESOURCES